Cardiomyopathy Tissue Bank in a Cancer Population
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00500734|
Recruitment Status : Recruiting
First Posted : July 13, 2007
Last Update Posted : January 27, 2020
Any time the words "you," "your," "I," or "me" appear, it is meant to apply to the potential participant.
The goal of this laboratory research study is to collect and store blood and tissue from patients who have a diagnosis of heart disease and may be at a high risk for the development of heart failure. This blood may be used in the future to identify genes that may play a role in developing congestive heart failure (CHF) from chemotherapy or other sources.
This is an investigational study. All will be enrolled at MD Anderson.
|Condition or disease||Intervention/treatment|
|Heart Disease||Procedure: Blood Sample|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Cardiomyopathy Tissue Bank in a Cancer Population|
|Actual Study Start Date :||December 10, 2002|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||December 2020|
|Heart Disease Patients||
Procedure: Blood Sample
One time blood draw of 2 teaspoons.
- Baseline Patient Demographic Information (age, sex, race) [ Time Frame: One time visit. ]
- Identification biological markers predisposing cancer patients to development of chemotherapy-induced congestive heart failure [ Time Frame: One time visit for collection of blood and tissue samples. ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00500734
|Contact: Jean-Bernard Durand, MDfirstname.lastname@example.org|
|United States, Texas|
|University of Texas MD Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Principal Investigator: Jean-Bernard Durand, MD|
|Principal Investigator:||Jean-Bernard Durand, MD||M.D. Anderson Cancer Center|